Combining GcMAF (Gc protein-derived macrophage activating factor) and stem cells for the treatment of autism spectrum disorder (ASD) offers several positive benefits. Here are some key advantages:

1. Immune System Modulation: GcMAF helps modulate the immune system, reducing inflammation and autoimmune responses which often contribute to autism.
2. Neuroinflammation Reduction: GcMAF can reduce neuroinflammation, which is often observed in children with autism.
3. Enhanced Neurogenesis: Stem cells promote the growth of new neurons, aiding in brain development and repair.
4. Improved Cognitive Function: Studies have shown that stem cell therapy can improve cognitive functions in children with autism.
5. Enhanced Social Skills: The combination can improve social interaction and communication skills in children with autism.
6. Reduction in Behavioural Issues: The therapy can help reduce behavioural issues such as aggression, self-injury, and repetitive behaviours.
7. Increased Attention Span: Children receiving this treatment may show an increased ability to sustain attention and focus.
8. Better Emotional Regulation: The therapy can help children with autism better regulate their emotions, leading to improved emotional stability.
9. Enhanced Sensory Processing: It can improve sensory processing, helping children with autism manage sensory stimuli better.
10. Improved Sleep Patterns: The combination can lead to better sleep patterns and quality of sleep with children with autism.
11. Enhanced Motor Skills: Stem cells can improve motor skills and coordination in children with autism.
12. Reduction in Anxiety: GcMAF can help reduce anxiety levels in children with autism, leading to a calmer demeanour.
13. Improved Gut Health: Stem cells can promote a healthy gut microbiome, which is often linked to autism.
14. Enhanced Learning Abilities: The therapy can improve learning abilities and academic performance in children with autism.
15. Better Response to Therapy: Children receiving this combination may show a better response to other therapeutic interventions.
16. Increased Alpha and Beta EEG Power: Studies have shown increased alpha and beta EEG power, indicating improved brain function.
17. Reduction in Epileptic Seizures: The combination can help reduce the frequency and severity of epileptic seizures in children with autism.
18. Improved Language Skills: Stem cells can enhance language development and communication skills.
19. Enhanced Eye Contact: The therapy can improve eye contact, which is often a challenge for children with autism.
20. Better Social Engagement: Children may show increased social engagement and interaction with peers.
21. Reduction in Hyperactivity: The combination can help reduce hyperactivity and impulsivity in children with autism.
22. Improved Quality of Life: Overall, the therapy can lead to an improved quality of life for children with autism and their families.
23. Enhanced Brain Connectivity: Stem cells can improve brain connectivity, aiding in better cognitive and social functions.
24. Reduction in Stereotypic Behaviours: The therapy can help reduce repetitive and stereotypic behaviours commonly seen in autism.
25. Improved Response to Medications: Children may show a better response to medications used to manage autism symptoms.
26. Enhanced Emotional Bonding: The combination can improve emotional bonding between children with autism and their caregivers.
27. Better Adaptation to Change: Children may show improved adaptability and flexibility in response to changes in their environment.
28. Increased Play Skills: The therapy can enhance play skills, which are crucial for social and cognitive development.
29. Improved Self-Care Skills: Children may develop better self-care skills, such as dressing and grooming.
30. Long-Term Benefits: The combination therapy may offer long-term benefits, leading to sustained improvements in autism symptoms.

Information regarding the stem cells used by Jose Fermin Celma a specialist in autism using both GcMaf and stem cells:

How cord blood stem cells are analyzed to determine if they come from donors who have not received any COVID-19 vaccines involves a few steps:
Protocol for the Analysis of Cord Blood Stem Cells and process:

1. 1st stage. Donor Screening and Documentation: The first method used is to rely on thorough donor screening and documentation. Donors are asked about their vaccination status, and this information is recorded and verified through medical records.2. 2nd stage is Flow Cytometry: This technique is used to analyses specific markers on the surface of stem cells. While flow cytometry is typically used to assess cell viability and count specific cell types, it’s adapted to detect markers or changes associated with Covid 19 variant vaccinations.

.3. 3rd stage. Genetic and Epigenetic Analysis: Advanced epigenetic analysis helps them reveal changes in gene expression or other markers that also indicates a history of COVID-19 vaccination.

4. 4th stage Serological Testing: Testing for the presence of antibodies specific to COVID-19 vaccines in the donor’s blood which is a strong indicator whether they have been vaccinated against COVID-19.
5. 5th stage: Cell Culture and Functional Assays: Culturing the stem cells and performing functional assays reveal differences in cell behavior or response to stimuli that are linked to COVID-19 vaccination status
   All cord blood stem cells derive from healthy donors.
   Other analysis to include:

* Sterility Testing: Cord blood samples are tested for microbial contamination to ensure they are free from harmful bacteria, viruses, and fungi. This is crucial to prevent infections in recipients.

* Infectious Disease Screening: The blood is tested for all infectious diseases such as HIV, hepatitis, and syphilis to ensure that the cells are safe for administration.
* Genetic Testing: While cord blood stem cells do not require a perfect blood match, genetic testing is still performed to ensure they are suitable for administration and to identify any potential genetic disorders.

* Quality Control: Throughout the processing and storage of cord blood, strict quality control measures are in place to maintain the integrity and viability of the stem cells. This includes monitoring the cells during cryopreservation (freezing) and ensuring proper handling and storage conditions

For further information https://www.stemcell-doctor.com/stemcellregenerativemedicine